MASON, OH and EINDHOVEN, THE NETHERLANDS / ACCESSWIRE / March 26, 2024 / InnoSIGN a clinical stage biotechnology company focused on democratizing precision medicine through its proprietary cell signaling pathway technology, today announced the appointment .